Further KEGG analysis revealed that these genes were highly enriched in the TGF-β1 pathway (Fig 3C), indicating a high correlation between the TGF-β1 pathway and the pathogenesis of AF and the therapeutic effect of vericiguat. Here, TGFB1 is linked to atrial fibrillation.